Multiple Product Franchises on the Horizon

Genomic Health is applying the same technology and clinical rigor used to develop the Oncotype DX breast, colon and prostate tests, to other cancers including, renal cell and lung cancers, as well as melanomas.

Learn more about Genomic Health's products in development:

• Breast Cancer 
• Colon Cancer 
• Prostate Cancer 
• Non-Small Cell Lung Cancer 
• Renal Cancer 
• Melanoma

Contact Genomic Health for more information about genomic analysis.